​
​

AnaptysBio (ANAB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

AnaptysBio Revenue Highlights

Latest Revenue (Y)

$17.16M

Latest Revenue (Q)

$30.02M

AnaptysBio Revenue by Period

AnaptysBio Revenue by Year

DateRevenueChange
2023-12-31-66.78%
2022-12-31--83.72%
2021-12-31--15.77%
2020-12-31-837.50%
2019-12-31-60.00%
2018-12-31--50.00%
2017-12-31--40.06%
2016-12-31--5.05%
2015-12-31-10.94%
2014-12-31-188.86%
2013-12-31--

AnaptysBio generated $17.16M in revenue during NA 2023, up 66.78% compared to the previous quarter, and up 343.14% compared to the same period a year ago.

AnaptysBio Revenue by Quarter

DateRevenueChange
2024-09-30-173.60%
2024-06-30-52.82%
2024-03-31--20.28%
2023-12-31-171.40%
2023-09-30--4.10%
2023-06-30-151.82%
2023-03-31--79.82%
2022-12-31-426.53%
2022-09-30-6.33%
2022-06-30-25.36%
2022-03-31--4.06%
2021-12-31--95.16%
2021-09-30--30.43%
2021-06-30-166.98%
2021-03-31--81.25%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31-400.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31--100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31-100.00%
2017-09-30--100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31--14.31%
2016-09-30--45.06%
2016-06-30-20.22%
2016-03-31-20.03%
2015-12-31--10.67%
2015-09-30--7.05%
2015-06-30-19.16%
2015-03-31-10.58%
2014-12-31--39.80%
2014-09-30--

AnaptysBio generated $30.02M in revenue during Q3 2024, up 173.60% compared to the previous quarter, and up 867.54% compared to the same period a year ago.

AnaptysBio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DCPHDeciphera Pharmaceuticals--
CTMXCytomX Therapeutics--
RYTMRhythm Pharmaceuticals--
ANABAnaptysBio--
CRNXCrinetics Pharmaceuticals--
KURAKura Oncology--

ANAB Revenue FAQ

What is AnaptysBio’s yearly revenue?

AnaptysBio's yearly revenue for 2023 was $17.16M, representing an increase of 66.78% compared to 2022. The company's yearly revenue for 2022 was $10.29M, representing a decrease of -83.72% compared to 2021. ANAB's yearly revenue for 2021 was $63.18M, representing a decrease of -15.77% compared to 2020.

What is AnaptysBio’s quarterly revenue?

AnaptysBio's quarterly revenue for Q3 2024 was $30.02M, a 173.60% increase from the previous quarter (Q2 2024), and a 804.67% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $10.97M, a 52.82% increase from the previous quarter (Q1 2024), and a 217.08% increase year-over-year (Q2 2023). ANAB's quarterly revenue for Q1 2024 was $7.18M, a -20.28% decrease from the previous quarter (Q4 2023), and a 422.49% increase year-over-year (Q1 2023).

What is AnaptysBio’s revenue growth rate?

AnaptysBio's revenue growth rate for the last 3 years (2021-2023) was -72.84%, and for the last 5 years (2019-2023) was 114.46%.